Tekla Capital Management’s Pyxis Oncology PYXS Stock Holding History

Tekla Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.81M	Hold	708,303	–	–	0.07%	115
2023 Q1	$2.84M	Hold	708,303	–	–	0.11%	104
2022 Q4	$949K	Hold	708,303	–	–	0.04%	135
2022 Q3	$1.4M	Hold	708,303	–	–	0.06%	122
2022 Q2	$1.69M	Hold	708,303	–	–	0.07%	118
2022 Q1	$2.63M	Buy	708,303 +573,303	+425%	+$4.19M	0.09%	116
2021 Q4	$1.48M	Buy	+135,000	New	+$1.55M	0.05%	133

Other funds holding PYXS

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tekla Capital Management's PYXS Position: Q2 2023 in Review

Tekla Capital Management held its Pyxis Oncology (PYXS) position steady in Q2 2023 at 708,303 shares worth $1.81M. The position accounts for 0.07% of the portfolio, ranked #115.

Tekla Capital Management first reported a position in PYXS in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.84M in Q1 2023. 48 funds tracked by Wall St. Rank hold PYXS as of Q2 2023.

Tekla Capital Management held 708,303 shares of Pyxis Oncology worth $1.81M as of Q2 2023.
Tekla Capital Management left its Pyxis Oncology share count unchanged in Q2 2023.
Pyxis Oncology made up 0.07% of Tekla Capital Management's portfolio in Q2 2023, its #115 holding.
Tekla Capital Management first reported a position in Pyxis Oncology in Q4 2021 and has held it in 7 quarters since.
Tekla Capital Management's Pyxis Oncology position peaked at $2.84M in Q1 2023.
48 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.